Mallinckrodt seeks to postpone or not pay $200M opioid payment, WSJ says

Mallinckrodt is aiming to delay or not pay in full the $200M payment due Friday to an opioid-victims compensation trust, the Wall Street Journal’s Alexander Gladstone reports, citing people familiar with the drugmaker’s planning. The company has suggested it might not make the payment and is in talks with financial creditors to seek waivers from potential defaults arising from nonpayment, the author notes.